About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 486290, 6 pages
http://dx.doi.org/10.1155/2013/486290
Research Article

Whole Blood Platelet Aggregation and Release Reaction Testing in Uremic Patients

1Department of Pathology, George Washington University Medical Center, 900 23rd Street NW, Washington, DC 20037, USA
2Department of Medicine, George Washington University Medical Center, Washington, DC 20037, USA

Received 3 April 2013; Revised 12 June 2013; Accepted 17 June 2013

Academic Editor: Giuseppe Valacchi

Copyright © 2013 Jay Zeck et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. L. Weigert and A. I. Schafer, “Uremic bleeding: pathogenesis and therapy,” American Journal of the Medical Sciences, vol. 316, no. 2, pp. 94–104, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. A. S. Sohal, A. S. Gangji, M. A. Crowther, and D. Treleaven, “Uremic bleeding: pathophysiology and clinical risk factors,” Thrombosis Research, vol. 118, no. 3, pp. 417–422, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. U. Bilgin, I. Karadogan, M. Artac, A. Kizilors, R. Bilgin, and L. Undar, “Hemodialysis shortens long in vitro closure times as measured by the PFA-100,” Medical Science Monitor, vol. 13, no. 3, pp. CR141–CR145, 2007. View at Scopus
  4. J. J. Zwaginga, M. J. W. Ijsseldijk, P. G. de Groot, J. Vos, R. L. J. de Bos Kuil, and J. J. Sixma, “Defects in platelet adhesion and aggregate formation in uremic bleeding disorder can be attributed to factors in plasma,” Arteriosclerosis and Thrombosis, vol. 11, no. 3, pp. 733–744, 1991. View at Scopus
  5. M. Noris and G. Remuzzi, “Uremic bleeding: closing the circle after 30 years of controversies?” Blood, vol. 94, no. 8, pp. 2569–2574, 1999. View at Scopus
  6. K. Pawlak, J. S. Malyszko, J. Malyszko, and M. Mysliwiec, “Effects of endothelin-1 on aggregation of normal and uremic platelets,” Pol J Pharmacol, vol. 48, pp. 185–190, 1996.
  7. S. A. Kozek-Langenecker, T. Masaki, H. Mohammad, W. Green, S. F. Mohammad, and A. K. Cheung, “Fibrinogen fragments and platelet dysfunction in uremia,” Kidney International, vol. 56, no. 1, pp. 299–305, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Bonomini, V. Sirolli, G. Merciaro et al., “Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine,” Nephrology Dialysis Transplantation, vol. 20, no. 2, pp. 361–366, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Kaw and D. Malhotra, “Platelet dysfunction and end-stage renal disease,” Seminars in Dialysis, vol. 19, no. 4, pp. 317–322, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Boccardo, G. Remuzzi, and M. Galbusera, “Platelet dysfunction in renal failure,” Seminars in Thrombosis and Hemostasis, vol. 30, no. 5, pp. 579–589, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. F. Elshamaa, E. A. Elghoroury, and A. Helmy, “Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia,” Blood Coagulation and Fibrinolysis, vol. 20, no. 4, pp. 230–239, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Bonomini, S. Dottori, L. Amoroso, A. Arduini, and V. Sirolli, “Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia,” Journal of Thrombosis and Haemostasis, vol. 2, no. 8, pp. 1275–1281, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. G. E. Linthorst, H. J. Avis, and M. Levi, “Uremic thrombocytopathy is not about urea,” Journal of the American Society of Nephrology, vol. 21, no. 5, pp. 753–755, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. G. V. R. Born, “Aggregation of blood platelets by adenosine diphosphate and its reversal,” Nature, vol. 194, no. 4832, pp. 927–929, 1962. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Sirolli, L. Strizzi, S. di Stante, I. Robuffo, A. Procopio, and M. Bonomini, “Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis,” Thrombosis and Haemostasis, vol. 86, no. 3, pp. 834–839, 2001. View at Scopus
  16. A. M. Dyszkiewicz-Korpanty, E. P. Frenkel, and R. Sarode, “Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods,” Clinical and Applied Thrombosis/Hemostasis, vol. 11, no. 1, pp. 25–35, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. D. C. Cardinal and R. J. Flower, “The electronic aggregometer: a novel device for assessing platelet behavior in blood,” Journal of Pharmacological Methods, vol. 3, no. 2, pp. 135–158, 1980. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Waki, A. Hayashi, S. Ikeda et al., “Measuring platelet aggregation in dialysis patients with a whole blood aggregometer by the screen filtration pressure method,” Therapeutic Apheresis and Dialysis, vol. 15, no. 2, pp. 203–206, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Remuzzi, A. Benigni, and P. Dodesini, “Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect,” Journal of Clinical Investigation, vol. 71, no. 3, pp. 762–768, 1983. View at Scopus
  20. A. S. Levey, P. E. de Jong, J. Coresh et al., “The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report,” Kidney International, vol. 80, no. 1, pp. 17–28, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. B. A. Konkle, “Acquired disorders of platelet function,” Hematology, vol. 2011, pp. 391–396, 2011. View at Scopus
  22. C. M. Ingerman-Wojenski and M. J. Silver, “A quick method for screening platelet dysfunctions using the whole blood lumi-aggregometer,” Thrombosis and Haemostasis, vol. 51, no. 2, pp. 154–156, 1984. View at Scopus
  23. M. E. Carr Jr. and E. J. Martin, “Evolving techniques for monitoring clotting in plasma and whole blood samples,” Clinical Laboratory, vol. 50, no. 9-10, pp. 539–549, 2004. View at Scopus
  24. D. F. Brophy, E. J. Martin, S. L. Carr, B. Kirschbaum, and M. E. Carr Jr., “The effect of uremia on platelet contractile force, clot elastic modulus and bleeding time in hemodialysis patients,” Thrombosis Research, vol. 119, no. 6, pp. 723–729, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. S.-J. Ho, R. Gemmell, and T. A. Brighton, “Platelet function testing in uraemic patients,” Hematology, vol. 13, no. 1, pp. 49–58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Joist, G. Remuzzi, and P. Mannucci, “Abnormal bleeding and thrombosis in renal disease,” in Hemostasis and Thrombosis: Basic Principles and Clinical Practice Philadelphia, R. Colman, J. Hirsh, V. Marder, and E. Salzman, Eds., pp. 921–935, J. B. Lippincott, Philadelphia, Pa, USA, 1994.
  27. T. A. Depner, “Uremic toxicity: urea and beyond,” Seminars in Dialysis, vol. 14, no. 4, pp. 246–251, 2001. View at Scopus
  28. M. Winter, G. Frampton, and A. Bennett, “Synthesis of thromboxane B2 in uraemia and the effects of dialysis,” Thrombosis Research, vol. 30, no. 3, pp. 265–272, 1983. View at Scopus
  29. A. Bloom, M. Greaves, F. E. Preston, and C. B. Brown, “Evidence against a platelet cyclooxygenase defect in uraemic subjects on chronic haemodialysis,” British Journal of Haematology, vol. 62, no. 1, pp. 143–149, 1986. View at Scopus
  30. I. Pietrzak, M. Komarnicki, and D. Zaremba-Drobnik, “Platelet aggregation and prostaglandin metabolism in uremic patients,” American Journal of Kidney Diseases, vol. 38, no. 4, pp. S111–S114, 2001. View at Scopus
  31. M. Pai, G. Wang, K. A. Moffat et al., “Diagnostic usefulness of a lumi-aggregometer adenosine triphosphate release assay for the assessment of platelet function disorders,” American Journal of Clinical Pathology, vol. 136, no. 3, pp. 350–358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. M. E. Carr Jr., “Development of platelet contractile force as a research and clinical measure of platelet function,” Cell Biochemistry and Biophysics, vol. 38, no. 1, pp. 55–78, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Harrison, “Measuring platelet function?” Hematology Journal, vol. 5, supplement 3, pp. S164–S169, 2004. View at Publisher · View at Google Scholar · View at Scopus